2024 Q2 Form 10-Q Financial Statement

#000149315224019385 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.270K $7.490K $10.22K
YoY Change -7.3% -26.71% 62.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $12.76K $10.00K $12.27K
YoY Change 27.6% -18.46% 47.8%
Operating Profit
YoY Change
Interest Expense -$10.00 -$20.00 -$50.00
YoY Change -60.0% 400.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$12.78K -$10.00K -$12.27K
YoY Change 27.8% -18.5% 47.65%
Income Tax
% Of Pretax Income
Net Earnings -$12.78K -$10.00K -$12.27K
YoY Change 2.82% -18.46% 47.62%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 7.070M shares 7.070M shares 7.070M shares
Diluted Shares Outstanding 7.070M shares 7.070M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00 $10.00 $0.00
YoY Change
Cash & Equivalents $13.00 $6.00 $4.00
Short-Term Investments
Other Short-Term Assets $2.800K $7.000K $6.650K
YoY Change 5.26% 74.54%
Inventory
Prepaid Expenses $2.800K $7.000K $6.650K
Receivables
Other Receivables
Total Short-Term Assets $2.810K $7.010K $6.650K
YoY Change 5.41% 74.54%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.00 -$4.00 -$4.00
YoY Change -99.89% 0.0%
TOTAL ASSETS
Total Short-Term Assets $2.810K $7.010K $6.650K
Total Long-Term Assets $3.00 -$4.00 -$4.00
Total Assets $2.813K $7.006K $6.646K
YoY Change 5.4% 5.42% 74.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $132.3K $127.2K $201.8K
YoY Change 164.5% -36.98% -3.11%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $284.1K $284.1K $201.6K
YoY Change 1.45% 40.93% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $821.9K $813.3K $765.6K
YoY Change 6.73% 6.22% 7.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $821.9K $813.3K $765.6K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $821.9K $813.3K $765.6K
YoY Change 6.17% 6.22% 7.62%
SHAREHOLDERS EQUITY
Retained Earnings -$926.1K -$913.3K -$866.0K
YoY Change 5.42% 5.46%
Common Stock $70.00 $70.00 $70.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$819.0K -$806.3K -$759.0K
YoY Change
Total Liabilities & Shareholders Equity $2.813K $7.006K $6.646K
YoY Change 5.4% 5.42% 74.44%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$12.78K -$10.00K -$12.27K
YoY Change 2.82% -18.46% 47.62%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.510K -$13.03K -$19.58K
YoY Change -96.1% -33.45% 104.6%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.510K 13.05K 19.58K
YoY Change -96.1% -33.35% 104.81%
NET CHANGE
Cash From Operating Activities -3.510K -13.03K -19.58K
Cash From Investing Activities
Cash From Financing Activities 3.510K 13.05K 19.58K
Net Change In Cash 0.000 20.00 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$3.510K -$13.03K -$19.58K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Entity Central Index Key
EntityCentralIndexKey
0001375348
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Cash
Cash
6 usd
CY2023Q2 us-gaap Cash
Cash
9 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7070000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7070000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
70 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
70 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
106990 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-913323 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-806263 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7006 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-35 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-35 usd
CY2024Q1 GLNS Bank Fees
BankFees
9 usd
CY2023Q1 GLNS Bank Fees
BankFees
13 usd
us-gaap Professional Fees
ProfessionalFees
10700 usd
us-gaap Professional Fees
ProfessionalFees
14928 usd
CY2024Q1 us-gaap Other General Expense
OtherGeneralExpense
2500 usd
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
2000 usd
us-gaap Other General Expense
OtherGeneralExpense
7500 usd
us-gaap Other General Expense
OtherGeneralExpense
6000 usd
CY2024Q1 us-gaap Legal Fees
LegalFees
5239 usd
CY2023Q1 us-gaap Legal Fees
LegalFees
5313 usd
us-gaap Legal Fees
LegalFees
16610 usd
us-gaap Legal Fees
LegalFees
12789 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
10002 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
12267 usd
us-gaap Operating Expenses
OperatingExpenses
34850 usd
us-gaap Operating Expenses
OperatingExpenses
33792 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10002 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12267 usd
us-gaap Net Income Loss
NetIncomeLoss
-34850 usd
us-gaap Net Income Loss
NetIncomeLoss
-33792 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7070000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7070000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7070000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7070000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7070000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7070000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7070000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7070000 shares
us-gaap Net Income Loss
NetIncomeLoss
-34850 usd
us-gaap Net Income Loss
NetIncomeLoss
-33792 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
4340 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
6650 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5142 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10870 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34048 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51312 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
34045 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
51309 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34045 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51309 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-771412 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-13513 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-784925 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-11335 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-796260 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10002 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-806263 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-725191 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-725191 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-19468 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-744660 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2057 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-746717 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12267 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-758984 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-758984 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_802_eus-gaap--NatureOfOperations_zBfU0x7shIR8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_828_z5RII8oeTShg">NATURE OF OPERATIONS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was incorporated in the State of Nevada, U.S.A. on April 21, 2006.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exploration Stage Activities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has been in the exploration stage since its formation and is primarily engaged in the acquisition and exploration of mining claims. Upon location of a commercial minable reserve, the Company expects to actively prepare the site for its extraction and enter a development stage.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The general business strategy of the Company is to acquire and explore mineral properties. The continued operations of the Company and the recoverability of mineral property costs is dependent upon the existence of economically recoverable mineral reserves, the ability of the Company to obtain necessary financing to complete the development of its properties, and upon future profitable production. The Company has not generated any revenues or completed development of any properties to date. Further, the Company has a working capital deficit of $<span id="xdx_900_ecustom--WorkingCapitalDeficit_iNI_di_c20240331_zRCuFOr79HTl" title="Working capital deficit">806,263</span> (June 30, 2023 - $<span id="xdx_906_ecustom--WorkingCapitalDeficit_iNI_di_c20230630_zalqF1K1o7oi" title="Working capital deficit">771,412</span>), has incurred losses of $<span id="xdx_904_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_di_c20240331_zQ5ixs7WN1I2" title="Accumulated deficit">913,323</span> since inception, and further significant losses are expected to be incurred in the exploration and development of its mineral properties. The Company will require additional funds to meet its obligations and maintain its operations. There can be no guarantee that the Company will be successful in raising the necessary financing. Management’s plans in this regard are to raise equity financing as required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed interim financial statements do not include any adjustments that might result from this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 GLNS Working Capital Deficit
WorkingCapitalDeficit
-806263 usd
CY2023Q2 GLNS Working Capital Deficit
WorkingCapitalDeficit
-771412 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-913323 usd
CY2013Q3 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
10 usd
CY2006Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6000000 shares
CY2006Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2006Q2 GLNS Number Of Founding Shareholders
NumberOfFoundingShareholders
2 integer
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
374030 usd
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
339985 usd

Files In Submission

Name View Source Status
0001493152-24-019385-index-headers.html Edgar Link pending
0001493152-24-019385-index.html Edgar Link pending
0001493152-24-019385.txt Edgar Link pending
0001493152-24-019385-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
form10-q_002.jpg Edgar Link pending
glns-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
glns-20240331_cal.xml Edgar Link unprocessable
glns-20240331_def.xml Edgar Link unprocessable
glns-20240331_lab.xml Edgar Link unprocessable
glns-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending